Roland Winterfield
Cardiovascular Disease · Palos Heights, ILNPI 1649293044
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Johnson & Johnson at 28.5% of the total. Reporting peaked in 2019 at $932 and has fallen 94.5% since, to $51 in 2022. That places this record below the midpoint for cardiovascular disease clinicians in IL, where the typical reported total is $1,479.
Across 90 payments — averaging $19.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$488
- Pfizer$211
- Acutus Medical, Inc.$192
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$183
- Boston Scientific$125
- Amarin Pharma, Inc.$94
- plus $418 from 14 others
What the payments were for
- Food & beverage$1,66197%
- Education$503%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 37 | $488 |
| Pfizer | 9 | $211 |
| Acutus Medical, Inc. | 1 | $192 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 15 | $183 |
| Boston Scientific | 1 | $125 |
| Amarin Pharma, Inc. | 5 | $94 |
| Sanofi-aventis U.S. LLC | 4 | $67 |
| Amgen | 3 | $60 |
| Novartis | 3 | $54 |
| AbbVie | 2 | $43 |
| Akcea Therapeutics, Inc. | 1 | $27 |
| Portola Pharmaceuticals, LLC | 1 | $25 |
| Edwards Lifesciences | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Abbott | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $18 |
| AstraZeneca | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,711 in reported general payments places this provider in the 50th percentile of 932 cardiovascular disease providers in Illinois.
Other cardiovascular disease in Palos Heights
- Sandeep NathanChicago$892K
- Alan BrownNaperville$858K
- Azmey MatariehElgin$762K
- Jay AlexanderBannockburn$744K
- Niraj VarmaMaywood$522K
- Boaz AvitallChicago$366K
- Akhil NarangChicago$363K
- Mark RabbatMaywood$363K
- Michael DavidsonChicago$317K
- Robert KochLibertyville$298K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.